Tianjin Conjustar Biotechnology Co., Ltd.
PrivateLast Round
Early Funding
Mar 25, 2025
Total Funding Raised
$41.55M
Company Overview
Tianjin Conjustar Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Tianjin. Its latest recorded funding round was an Early Funding round in March 2025.
Tianjin Conjustar Biotechnology Co., Ltd. is a biotechnology company that researches and develops peptide-drug conjugates and nanobody-drug conjugates for oncology treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tianjin Conjustar Biotechnology Co., Ltd. Comparables
Compare Tianjin Conjustar Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MultiValent Biotherapies | 83% | |
| AnexAPep Inc. | 83% | |
| Cybrexa Therapeutics | 82% |
For institutional investors. Book with your work email.
Tianjin Conjustar Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 25, 2025 | ||||
| Angel | Feb 1, 2023 | ||||
| Seed | Mar 1, 2022 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2023
Raised $8.05M in an angel funding round.
- Mar 1, 2022
$7.17M round with Fosun Health Capital and WuXi AppTec
For institutional investors. Book with your work email.
Tianjin Conjustar Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tianjin Conjustar Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Tianjin Conjustar Biotechnology Co., Ltd. a public or private company?
Tianjin Conjustar Biotechnology Co., Ltd. is a private company.
What is the current stock price of Tianjin Conjustar Biotechnology Co., Ltd.?
Tianjin Conjustar Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Tianjin Conjustar Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tianjin Conjustar Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Tianjin Conjustar Biotechnology Co., Ltd. is not publicly available.
Can I buy Tianjin Conjustar Biotechnology Co., Ltd. stock?
Tianjin Conjustar Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tianjin Conjustar Biotechnology Co., Ltd.'s last funding round?
Tianjin Conjustar Biotechnology Co., Ltd.'s most recent funding round was Early Funding on March 25, 2025.
Who are the main investors in Tianjin Conjustar Biotechnology Co., Ltd.?
Investor information for Tianjin Conjustar Biotechnology Co., Ltd. is not publicly disclosed.
Will Tianjin Conjustar Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Tianjin Conjustar Biotechnology Co., Ltd..
How can I track Tianjin Conjustar Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Tianjin Conjustar Biotechnology Co., Ltd.'s shares on secondary markets.